Patents by Inventor Jeffrey C. GAULDING

Jeffrey C. GAULDING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Abuse and Misuse Deterrent Transdermal Systems
    Publication number: 20220125739
    Abstract: An abuse deterrent and misuse deterrent transdermal patch comprising aversive agents incorporated in the backing layer of the patch. The aversive agents can exhibit biphasic or sustained kinetics of release with an immediate portion released rapidly and an extended portion released in a prolonged manner when exposed to a dissolution medium. The prolonged aversive agent release provides deterrence against extraction of drug from fresh and used patches and serves to prevent accidental misuse of used patches by children. The abuse deterrent and misuse deterrent patch systems can be used for transdermal delivery of therapeutically active agents and particularly those drugs that are highly prone to abuse such as opiate and opioid analgesics and stimulants.
    Type: Application
    Filed: January 5, 2022
    Publication date: April 28, 2022
    Inventors: David James ENSCORE, Frank TAGLIAFERRI, Steven Paul DAMON, Alan SMITH, Jeffrey C. GAULDING
  • Abuse and Misuse Deterrent Transdermal Systems
    Publication number: 20200113845
    Abstract: An abuse deterrent and misuse deterrent transdermal patch comprising aversive agents incorporated in the backing layer of the patch. The aversive agents can exhibit biphasic or sustained kinetics of release with an immediate portion released rapidly and an extended portion released in a prolonged manner when exposed to a dissolution medium. The prolonged aversive agent release provides deterrence against extraction of drug from fresh and used patches and serves to prevent accidental misuse of used patches by children. The abuse deterrent and misuse deterrent patch systems can be used for transdermal delivery of therapeutically active agents and particularly those drugs that are highly prone to abuse such as opiate and opioid analgesics and stimulants.
    Type: Application
    Filed: December 9, 2019
    Publication date: April 16, 2020
    Inventors: David James ENSCORE, Frank TAGLIAFERRI, Steven Paul DAMON, Alan SMITH, Jeffrey C. GAULDING
  • ABUSE AND MISUSE DETERRENT TRANSDERMAL SYSTEMS
    Publication number: 20170007550
    Abstract: An abuse deterrent and Misuse deterrent transdermal patch comprising aversive agents incorporated in the backing layer of the patch. The aversive agents can exhibit biphasic or sustained kinetics of release with an immediate portion released rapidly and an extended portion released in a prolonged manner when exposed to a dissolution medium. The prolonged aversive agent release provides deterrence against extraction of drug from fresh and used patches and serves to prevent accidental misuse of used patches by children. The abuse deterrent and misuse deterrent patch systems can be used for transdermal delivery of therapeutically active agents and particularly those drugs that are highly prone to abuse such as opiate and opioid analgesics and stimulants.
    Type: Application
    Filed: January 21, 2015
    Publication date: January 12, 2017
    Inventors: David James ENSCORE, Frank TAGLIAFERRI, Steven Paul DAMON, Alan SMITH, Jeffrey C. GAULDING